New Daily Persistent Headache Survey

New Daily Persistent Headache Clinical Trial

— NDPH  

Official title:

New Daily Persistent Headache Patient Experience Survey

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05984719
• Other study ID #: HSC-MS-23-0206
• Status: Active, not recruiting
• Start date: June 19, 2023
• Est. completion date: August 31, 2025

Study information

• Verified date: March 2024
• Source: The University of Texas Health Science Center, Houston
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Purpose: to explore headache characteristics and treatment effects of patient with new daily persistent headache (NDPH) through an online survey.

Research design: Online survey of patients with new daily persistent headache.

Risks: Risks include a breach of confidentiality as well as fatigue from taking the survey online.

Importance of knowledge that may recently be expected to result: The study aims to discover new information in a very understudied disease. This information could, in future studies, help change the diagnostic criteria or lead to new treatment options.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 10000
• Est. completion date: August 31, 2025
• Est. primary completion date: January 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 13 Years and older

Eligibility

Inclusion Criteria:

• Patients with NDPH that have been diagnosed by a health care professional (no documentation is needed, participant must simply state that he or she has been diagnosed)

Exclusion Criteria:

• Unable to speak English (the survey is only in English)

• Unable to use a computer to take the online survey

Related Conditions & MeSH terms

• Headache
• New Daily Persistent Headache
• New Daily Persistent Headache (NDPH)

Locations

Country	Name	City	State
United States	UTHealth Houston	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Survey data		At study completion, expected to be in 6-12 months.

External Links

•   Link to the online survey - participants can go here directly. (For more information first, call the study team at 713.486.7771 or email the study team at nctt.wec@uth.tmc.edu)